This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Brina Ornik: Innovator in Pharmaceutical Chemistry
Introduction
Brina Ornik is a notable inventor based in Ljubljana, Slovenia. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel drug formulations. Her work has implications for the treatment of gastrointestinal disorders, showcasing her commitment to advancing medical science.
Latest Patents
Brina Ornik holds a patent for a crystalline form of omeprazole. This novel crystalline form, known as omeprazole form C, is characterized by its chemical composition, specifically 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfiny]-1H-benzimidazole. The patent also details a process for preparing omeprazole form C, a pharmaceutical formulation containing this compound, and its use in treating gastrointestinal disorders. She has 1 patent to her name.
Career Highlights
Brina Ornik is currently employed at Lek Pharmaceuticals D.d., a leading pharmaceutical company in Slovenia. Her role involves research and development, where she applies her expertise to create innovative solutions in drug formulation. Her contributions have been instrumental in enhancing the efficacy of pharmaceutical products.
Collaborations
Brina has collaborated with several professionals in her field, including her coworkers Alenka Kosak and Anton Copar. These collaborations have fostered a productive environment for innovation and have led to advancements in their shared projects.
Conclusion
Brina Ornik's work exemplifies the impact of innovation in the pharmaceutical industry. Her contributions, particularly in the development of omeprazole form C, highlight her dedication to improving healthcare solutions. Through her career at Lek Pharmaceuticals D.d., she continues to influence the field positively.